RecruitingNCT07041450

Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
MoCA Clinic and Institute
Principal Investigator
Ziad Nasreddine, MD
MoCA Clinic
Intervention
Digital MoCA(diagnostic_test)
Enrollment
500 enrolled
Eligibility
55-90 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Collaborators

C2N Diagnostics

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07041450 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials